CDK1 dysregulation promotes tumor development through multiple mechanisms: it drives unscheduled mitosis, leading to genomic instability and aneuploidy [44]; phosphorylates key survival proteins, preventing apoptosis of damaged cells [45]; and contributes to therapy resistance through interaction with DNA damage repair pathways. The gene discussed is CDK1; the disease is neoplasm.